These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 37458869)

  • 1. Rodent models to study type 1 and type 2 diabetes induced human diabetic nephropathy.
    Talukdar A; Basumatary M
    Mol Biol Rep; 2023 Sep; 50(9):7759-7782. PubMed ID: 37458869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Animal Models of Diabetes-Associated Renal Injury.
    Noshahr ZS; Salmani H; Khajavi Rad A; Sahebkar A
    J Diabetes Res; 2020; 2020():9416419. PubMed ID: 32566684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revisiting Experimental Models of Diabetic Nephropathy.
    Giralt-López A; Molina-Van den Bosch M; Vergara A; García-Carro C; Seron D; Jacobs-Cachá C; Soler MJ
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32438732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A translational model of chronic diabetic nephropathy in the Nile grass rat.
    Naseri M; Ranaei Pirmardan E; Melhorn MI; Zhang Y; Barakat A; Hafezi-Moghadam A
    FASEB J; 2024 Jul; 38(14):e23789. PubMed ID: 39018098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated levels of renal and circulating Nop-7-associated 2 (NSA2) in rat and mouse models of diabetes, in mesangial cells in vitro and in patients with diabetic nephropathy.
    Shahni R; Gnudi L; King A; Jones P; Malik AN
    Diabetologia; 2012 Mar; 55(3):825-34. PubMed ID: 22095236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic kidney lesions of GIPRdn transgenic mice: podocyte hypertrophy and thickening of the GBM precede glomerular hypertrophy and glomerulosclerosis.
    Herbach N; Schairer I; Blutke A; Kautz S; Siebert A; Göke B; Wolf E; Wanke R
    Am J Physiol Renal Physiol; 2009 Apr; 296(4):F819-29. PubMed ID: 19211686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rethinking glomerular basement membrane thickening in diabetic nephropathy: adaptive or pathogenic?
    Marshall CB
    Am J Physiol Renal Physiol; 2016 Nov; 311(5):F831-F843. PubMed ID: 27582102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex differences in progression of diabetic nephropathy in OVE26 type 1 diabetic mice.
    Wang W; Jiang S; Tang X; Cai L; Epstein PN; Cheng Y; Sun W; Xu Z; Tan Y
    Biochim Biophys Acta Mol Basis Dis; 2020 Jan; 1866(1):165589. PubMed ID: 31678163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of diabetic nephropathy in a transgenic model of hypoinsulinemic diabetes.
    Kanetsuna Y; Hirano K; Nagata M; Gannon MA; Takahashi K; Harris RC; Breyer MD; Takahashi T
    Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1315-22. PubMed ID: 16705146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rodent animal models: from mild to advanced stages of diabetic nephropathy.
    Kaur M; Bedi O; Sachdeva S; Reddy BV; Kumar P
    Inflammopharmacology; 2014 Oct; 22(5):279-93. PubMed ID: 25149089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of immunoglobulin G deposit in glomeruli in Chinese patients with diabetic nephropathy.
    Zhang J; Zhang J; Zhang R; Wang Y; Liang Y; Yang Z; Wang T; Xu X; Liu F
    J Diabetes; 2020 Jul; 12(7):521-531. PubMed ID: 32031751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathology of human diabetic nephropathy.
    Najafian B; Alpers CE; Fogo AB
    Contrib Nephrol; 2011; 170():36-47. PubMed ID: 21659756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of diabetic nephropathy complicating non-diabetic renal disease among Chinese patients with type 2 diabetes mellitus.
    Zhuo L; Zou G; Li W; Lu J; Ren W
    Eur J Med Res; 2013 Feb; 18(1):4. PubMed ID: 23432977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural involvement in type 1 and type 2 diabetic nephropathy.
    Dalla Vestra M; Saller A; Bortoloso E; Mauer M; Fioretto P
    Diabetes Metab; 2000 Jul; 26 Suppl 4():8-14. PubMed ID: 10922968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel mouse model of advanced diabetic kidney disease.
    Thibodeau JF; Holterman CE; Burger D; Read NC; Reudelhuber TL; Kennedy CR
    PLoS One; 2014; 9(12):e113459. PubMed ID: 25514595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of intrarenal product TNF-alpha in the development of glomerular and tubulointerstitial tissues changes in elderly patients with diabetic nephropathy].
    Rakitianskaia IA; Riabov SI; Azanchevskaia SV; Riabova TS; Al-Barbari K; Gurkov AS; Popova VB
    Adv Gerontol; 2013; 26(4):658-65. PubMed ID: 24738256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tubular overexpression of Gremlin in transgenic mice aggravates renal damage in diabetic nephropathy.
    Marchant V; Droguett A; Valderrama G; Burgos ME; Carpio D; Kerr B; Ruiz-Ortega M; Egido J; Mezzano S
    Am J Physiol Renal Physiol; 2015 Sep; 309(6):F559-68. PubMed ID: 26155842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New experimental models of diabetic nephropathy in mice models of type 2 diabetes: efforts to replicate human nephropathy.
    Soler MJ; Riera M; Batlle D
    Exp Diabetes Res; 2012; 2012():616313. PubMed ID: 22461787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific down-regulation of connective tissue growth factor attenuates progression of nephropathy in mouse models of type 1 and type 2 diabetes.
    Guha M; Xu ZG; Tung D; Lanting L; Natarajan R
    FASEB J; 2007 Oct; 21(12):3355-68. PubMed ID: 17554073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the Hp 2-2 diabetic mouse model a good model to study diabetic nephropathy?
    Nakhoul F; Nakhoul N; Asleh R; Miller-Lotan R; Levy AP
    Diabetes Res Clin Pract; 2013 Jun; 100(3):289-97. PubMed ID: 23490597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.